HIF1A and neoplasm: The activity of both enzymes increases in hypoxic tumour microenvironments and is linked to the silencing of tumour suppressor genes and survival in breast cancer [35], while EZH2 transcription is enhanced by HIF-1α to promote more aggressive phenotypes [36].